| 2495 |
1931: Disruption of the intestinal barrier |
1868: Hyperinflammation |
Oct 19, 2021 |
Feb 8, 2023 |
None
|
| 3335 |
1931: Disruption of the intestinal barrier |
2257: Celiac disease |
Aug 13, 2024 |
Feb 27, 2025 |
1 AOP
|
| 3564 |
2339: Intracellular copper, increased |
1632: Increase in RONS |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3571 |
2339: Intracellular copper, increased |
2340: Oligomerisation of DLAT, increased |
Aug 13, 2025 |
Aug 13, 2025 |
1 AOP
|
| 3574 |
2339: Intracellular copper, increased |
2342: Fe-S cluster assembly, impaired |
Aug 13, 2025 |
Aug 13, 2025 |
1 AOP
|
| 3575 |
2342: Fe-S cluster assembly, impaired |
1477: OXPHOS, decreased |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3578 |
2342: Fe-S cluster assembly, impaired |
889: Proteostasis, impaired |
Aug 13, 2025 |
Aug 13, 2025 |
1 AOP
|
| 3580 |
2342: Fe-S cluster assembly, impaired |
2341: TCA cycle, disrupted |
Aug 13, 2025 |
Aug 13, 2025 |
1 AOP
|
| 3709 |
2342: Fe-S cluster assembly, impaired |
178: Mitochondrial electron transport chain, disrupted |
Jan 7, 2026 |
Jan 7, 2026 |
1 AOP
|
| 1167 |
1134: Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle |
1131: Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carbo |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1774 |
1434: Irritation induced sneezing |
1223: Increased Airway Hyper-responsiveness,Cough, Dyspnea |
Sep 24, 2018 |
Sep 24, 2018 |
None
|
| 955 |
927: S-Glutathionylation, eNOS |
932: Uncoupling, eNOS |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 3692 |
2389: Altered steroidogenesis |
2390: reproductive hormonal Imbalance |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 952 |
935: Decrease, GTPCH-1 |
934: Decrease, Tetrahydrobiopterin |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 953 |
934: Decrease, Tetrahydrobiopterin |
932: Uncoupling, eNOS |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 956 |
932: Uncoupling, eNOS |
933: Depletion, Nitric Oxide |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 3014 |
932: Uncoupling, eNOS |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3023 |
932: Uncoupling, eNOS |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 988 |
973: Decrease, AKT/eNOS activity |
933: Depletion, Nitric Oxide |
Nov 29, 2016 |
Oct 16, 2017 |
1 AOP
|
| 3694 |
2390: reproductive hormonal Imbalance |
2391: Reduced fertility |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 958 |
933: Depletion, Nitric Oxide |
937: Impaired, Vasodilation |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 982 |
937: Impaired, Vasodilation |
951: Increase, Vascular Resistance |
Nov 29, 2016 |
Oct 13, 2017 |
1 AOP
|
| 983 |
951: Increase, Vascular Resistance |
952: Hypertension |
Nov 29, 2016 |
Oct 13, 2017 |
1 AOP
|
| 2152 |
1795: TGFbeta expression |
1283: Activation, TGF-beta pathway |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 1778 |
1494: Leukocyte recruitment/activation |
265: Increase, HSC activation |
Nov 12, 2018 |
Nov 12, 2018 |
1 AOP
|